Search

everythinglearnresearchcommunity

for

Search:↓

Ritlecitinib helps regrow hair in people with alopecia totalis and universalis and is safe to use.

Abrocitinib may effectively treat stubborn alopecia universalis.

A new skin disease in four Labrador retrievers responded well to immunosuppressive treatment.

Tofacitinib helped an 8-year-old child recover from a type of hair loss that is hard to treat.

Cutaneous lupus patients have higher levels of certain immune cells in their blood and skin.

The treatment was effective for advanced non-Hodgkin's lymphomas.

A man developed autoimmune issues after a transplant, improved with treatment, but died from leukemia relapse.

A rare type of skin cancer with mucosal involvement was partially treated but eventually relapsed.

Ritlecitinib effectively reduces severe hair loss in alopecia areata over 24 months.

Ruxolitinib helped a patient with alopecia areata regrow hair.

Tranilast successfully treated a man's skin sarcoidosis when other treatments failed.

Infliximab successfully treated a severe hair loss case in Sri Lanka.

Using regulatory T cells and Rapamycin together improves chronic graft-versus-host disease treatment outcomes in mice.

Mycophenolate mofetil improved skin condition in a man with nephrogenic fibrosing dermopathy.

Telitacicept effectively improved hair regrowth in a woman with lupus and alopecia.

Adalimumab improved folliculitis decalvans in most patients.

A patient with advanced kidney cancer and no hepatitis C developed skin inflammation due to a drug called interferon alpha-2a.

Ritlecitinib is more effective and cheaper than baricitinib for treating severe alopecia areata.

A man developed a skin cancer called folliculotropic mycosis fungoides after a kidney transplant.

Switching to ritlecitinib improves hair regrowth and well-being in severe alopecia areata patients.

Ritlecitinib shows promise for treating alopecia areata, especially with early and extended treatment.

Ritlecitinib effectively maintains hair regrowth in alopecia areata patients.

Tofacitinib improved ulcerative colitis, skin ulcers, and hair loss in a patient who didn't respond well to other treatments.

JAK inhibitors may help treat alopecia areata by reversing hair loss.

Bortezomib chemotherapy can cause temporary skin rashes.

Immunoadsorption successfully treated a man's resistant polymyositis.

A patient with lupus and long-term hair loss saw significant hair regrowth after using the drug tofacitinib.

A man with Acrodermatitis continua did not get better with etanercept treatment, and his condition worsened, suggesting treatment effectiveness may vary by genetics and race.

Ritlecitinib helps regrow hair in alopecia areata and is safe for long-term use.